Skip to Content
Merck
  • Immunohistochemical analysis for histopathological subtypes in pediatric medulloblastomas.

Immunohistochemical analysis for histopathological subtypes in pediatric medulloblastomas.

Pathology international (2003-02-18)
Eun-Ik Son, Il-Man Kim, Dong-Won Kim, Man Bin Yim, Yu-Na Kang, Sang-Sook Lee, Kun-Young Kwon, Seong-Il Suh, Taeg-Kyu Kwon, Jung-Jeung Lee, Dong-Sug Kim, Sang-Pyo Kim
ABSTRACT

Medulloblastomas occurring in children represent a histological spectrum of varying anaplasia and nodularity. In order to determine whether immunohistochemical markers might be useful parameters in subclassifying these tumors, 17 pediatric medulloblastomas, including nine diffuse/non-anaplastic, four diffuse/anaplastic, three nodular/non-anaplastic and one nodular/anaplastic subtypes, were studied. In the present report, we investigate the expression of neural cell adhesion molecule (NCAM), nerve growth factor receptor (NGFR), neurofilament (NF), synaptophysin (SYN), glial fibrillary acidic protein (GFAP), S100, Bcl-2, and Ki-67 by using the immunohistochemistry against specific antibodies. This study showed that NGFR, NF, GFAP and S100 were not detected in anaplastic subtypes of medulloblastomas (0/5), while non-anaplastic subtypes were mainly expressed within the nodules. All 17 tumors were reactive for NCAM, SYN and Bcl-2. In addition, Ki-67 labeling indices for anaplastic subtypes (39.0 +/- 7.42%) were significantly higher than that of non-anaplastic medulloblastomas (11.4 +/- 8.04%; P < 0.0001). These results suggest that immunohistochemical markers are a useful adjunct in characterizing subtypes of pediatric medulloblastomas.